Advertisement
YOU ARE HERE: LAT HomeCollectionsPrincipia Pharmaceutical Corp
IN THE NEWS

Principia Pharmaceutical Corp

MORE STORIES ABOUT:
FEATURED ARTICLES
BUSINESS
September 12, 2000 | Bloomberg News
Human Genome Sciences Inc. said it bought Principia Pharmaceutical Corp., a closely held drug development company, for about $120 million in stock. The purchase gives Rockville, Md.-based Human Genome Sciences "protein technology which may solve three of the long-standing problems affecting production and commercial optimization of biological products--the length of time that the protein lasts within the body, delivery of the product and product stability," said spokesman Craig Rosen.
ARTICLES BY DATE
BUSINESS
September 12, 2000 | Bloomberg News
Human Genome Sciences Inc. said it bought Principia Pharmaceutical Corp., a closely held drug development company, for about $120 million in stock. The purchase gives Rockville, Md.-based Human Genome Sciences "protein technology which may solve three of the long-standing problems affecting production and commercial optimization of biological products--the length of time that the protein lasts within the body, delivery of the product and product stability," said spokesman Craig Rosen.
Los Angeles Times Articles
|